Global, regional, and national burden of lower respiratory infections and chronic obstructive pulmonary disease, 1990-2021: a systematic analysis from the global burden of disease study 2021
- PMID: 40455385
- DOI: 10.1007/s15010-025-02566-0
Global, regional, and national burden of lower respiratory infections and chronic obstructive pulmonary disease, 1990-2021: a systematic analysis from the global burden of disease study 2021
Abstract
Purpose: This study evaluates the global burden of lower respiratory infections (LRIs) and chronic obstructive pulmonary disease (COPD), focusing on their combined impact across age groups and regions.
Methods: Data from 204 countries were analyzed using spatiotemporal Gaussian process regression to estimate LRI and COPD incidence, prevalence, and disability-adjusted life years (DALYs). Age-standardized ratios (ASR) and the Socio-Demographic Index (SDI) were used to compare disease burdens, with trends assessed via linear regression and restricted cubic spline models.
Results: In 2021, COPD and LRI caused 360 million cases and 5.9 million deaths, with the highest burden in low-SDI regions. COPD remained the fourth leading cause of death, while LRI dropped to seventh.
Conclusion: The bidirectional link between LRI and COPD exacerbates disease progression, disproportionately affecting low-income regions and aging populations. Addressing disparities in healthcare access, improving vaccines, and strengthening public health infrastructure are critical to reducing the global burden of these diseases.
Keywords: COPD; Chronic obstructive pulmonary disease; LRI; Lower respiratory infections.
© 2025. Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical approval: All data was downloaded on September 24, 2024 from the GBD 2021 database. As this study is based on the GBD 2021 database, which is open to the public. Therefore the Institutional Ethics Committee granted an exemption for this study as it did not require approval. The study adhered to the guidelines for accurate and transparent reporting of health assessments and information that could identify individual participants was not available. Competing interests: The authors declare no competing interests.
References
-
- National Health Commission of the People’s Republic of China. (2024). Implementation plan for the prevention and control of chronic respiratory diseases in the healthy China action (2024–2030). China Government Network. https://www.gov.cn/zhengce/zhengceku/202407/content_6964998.htm
-
- Yang FF, Yu SJ, Du WN, et al. Global morbidity and mortality of lower respiratory infections: A population -based study. Respir Med. 2022;205:107042. https://doi.org/10.1016/j.rmed.2022.107042 . - DOI - PubMed
-
- GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators. Global, regional, and National incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the global burden of disease study 2021. Lancet Infect Dis. 2024;24(9):974–1002. https://doi.org/10.1016/S1473-3099(24)00176-2 . - DOI
-
- GBD2021URIOMC. Global, regional, and National burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the global burden of disease study 2021 [published correction appears in lancet infect dis. 2025;25(1):e13. Doi: 10.1016/S1473-3099(24)00830-2]. Lancet Infect Dis. 2025;25(1):36–51. https://doi.org/10.1016/S1473-3099(24)00430-4 .
-
- Hayden LP, Hobbs BD, Cohen RT et al. Childhood pneumonia increases risk for chronic obstructive pulmonary disease: the COPDGene study. Respir Res. 2015;16(1):115. Published 2015 Sep 21. https://doi.org/10.1186/s12931-015-0273-8
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical